European Sepsis Care Survey

The objective of this survey is to investigate the current state of sepsis care around Europe. The study is aiming at hospital structure, emergency departments, wards, intensive care units and clinical diagnostic and microbiological service.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sepsis Infections Inflammation Pathologic Processes Pathological Conditions, Signs and Symptoms Systemic Inflammatory Response Syndrome

Sex eligibility

All sexes

Study type

Observational

Primary location

Emergency Department Antwerp University Hospital, Edegem, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Hospitals of all strata

Exclusion criteria

Treatment and study plan

Primary outcomes

Questionnaire

Time frame: 2021

Structure of sepsis care in Europe

Sponsors and collaborators

Lead sponsor

University Medicine Greifswald

Other

Collaborators

Becton, Dickinson and Company
European Sepsis Alliance
European Shock Society
European Society for Emergency Medicine (EUSEM) Research Network
European Society of Anaesthesiology and Intensive Care
European Society of Clinical Microbiology and Infectious Diseases, ESGBIES Study Group
European Society of Intensive Care Medicine
Sepsisdialog, Germany

Registry information

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Sep 28, 2021
Registry last updated: Jun 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed